Moleculin Biotech, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Moleculin Biotech, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 13, 2025

Earnings release8-K

Quarterly report10-Q

Study Update

Jun 5, 2025

Press release

Q1 2025

May 14, 2025

Transcript

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 24, 2025

Transcript

Earnings release8-K

Annual report10-K

Q3 2024

Nov 11, 2024

Earnings release8-K

Quarterly report10-Q

Q2 2024

Aug 14, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 13, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 25, 2024

Earnings release8-K

Annual report10-K

Q3 2023

Nov 13, 2023

Quarterly report10-Q

Earnings release8-K

Q2 2023

Aug 11, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 11, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 23, 2023

Earnings release8-K

Annual report10-K

2021

Q4 2021

Mar 24, 2022

Annual report10-K

2020

Q4 2020

Mar 24, 2021

Annual report10-K

2019

Q4 2019

Mar 19, 2020

Annual report10-K

2018

Q4 2018

Feb 21, 2019

Annual report10-K

2017

Q4 2017

Mar 28, 2018

Annual report10-K

2016

Q4 2016

Apr 3, 2017

Annual report10-K